OUMOU DIALLO: Open Payments
NPI 1558006635 · HERSHEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 13 payments from 10 companies in 2025. Trend: 2023 $4,500 · 2024 $3,392 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| BeiGene USA, Inc. | 2 | $175 |
| ABBVIE INC. | 3 | $139 |
| E.R. Squibb & Sons, L.L.C. | 1 | $132 |
| Syndax Pharmaceuticals, Inc. | 1 | $108 |
| Gilead Sciences, Inc. | 1 | $107 |
| Exelixis Inc. | 1 | $98 |
| Novocure Inc. | 1 | $59 |
| Daiichi Sankyo Inc. | 1 | $25 |
| SERVIER PHARMACEUTICALS LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: BRUKINSA, OPDIVO, EMRELIS, REVUFORJ, CABOMETYX, Optune Lua (NovoTTF-200T), QULIPTA, DATROWAY.
Industry payments across PA — which companies pay providers there.
